Hepatitis D virus: Improving virological knowledge to develop new treatments
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis D virus: Improving virological knowledge to develop new treatments
Authors
Keywords
-
Journal
ANTIVIRAL RESEARCH
Volume 209, Issue -, Pages 105461
Publisher
Elsevier BV
Online
2022-11-14
DOI
10.1016/j.antiviral.2022.105461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
- (2022) Eloi R. Verrier et al. ANTIVIRAL RESEARCH
- Petabase-scale sequence alignment catalyses viral discovery
- (2022) Robert C. Edgar et al. NATURE
- Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—Results of A “real world” Study
- (2022) Mathias Jachs et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus
- (2022) Carla Usai et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
- (2022) H. Wedemeyer et al. DIGESTIVE AND LIVER DISEASE
- Hepatitis delta treatment with bulevirtide in real life: a case report
- (2022) Marc-Antoine GIORDAN et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis
- (2022) Caroline Schwarz et al. JOURNAL OF HEPATOLOGY
- Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
- (2022) Toni Herta et al. Pathogens
- Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension
- (2022) Elisabetta Degasperi et al. JOURNAL OF HEPATOLOGY
- Diversification of mammalian deltaviruses by host shifting
- (2021) Laura M. Bergner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of novel avian and mammalian deltaviruses provides new insights into deltavirus evolution
- (2021) Masashi Iwamoto et al. Virus Evolution
- Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real life
- (2021) Tarik Asselah et al. LIVER INTERNATIONAL
- Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
- (2021) Tyng-Yuan Jang et al. Scientific Reports
- New therapies for hepatitis delta virus infection
- (2021) Dimitri Loureiro et al. LIVER INTERNATIONAL
- HDV-Like Viruses
- (2021) Jimena Pérez-Vargas et al. Viruses-Basel
- HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
- (2021) Imme Roggenbach et al. Viruses-Basel
- Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis
- (2021) Alessandro Loglio et al. JOURNAL OF HEPATOLOGY
- Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis
- (2021) Lin-Yuan Chen et al. Gut Pathogens
- Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development
- (2020) Issam Tout et al. JOURNAL OF HEPATOLOGY
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
- (2020) Alexander J. Stockdale et al. JOURNAL OF HEPATOLOGY
- Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles
- (2020) Leonora Szirovicza et al. mBio
- Preliminary evidence for hdv exposure in apparently non‐HBV‐infected patients
- (2020) Isabelle Chemin et al. HEPATOLOGY
- Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodentProechimys semispinosus
- (2020) Sofia Paraskevopoulou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis B Virus Entry into Cells
- (2020) Charline Herrscher et al. Cells
- 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
- (2020) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- Bulevirtide: First Approval
- (2020) Connie Kang et al. DRUGS
- A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
- (2020) Christopher Koh et al. JOURNAL OF HEPATOLOGY
- No Evidence of Hepatitis C Virus (HCV)–Assisted Hepatitis D Virus Propagation in a Large Cohort of HCV-Positive Blood Donors
- (2020) Pierre Cappy et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis delta virus propagation enabled by hepatitis C virus—Scientifically intriguing, but is it relevant to clinical practice?
- (2020) Lisa Sophie Pflüger et al. JOURNAL OF VIRAL HEPATITIS
- Murine hepatocytes do not support persistence of Hepatitis D virus mono‐infection in vivo
- (2020) Katja Giersch et al. LIVER INTERNATIONAL
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
- (2019) Heiner Wedemeyer et al. LANCET INFECTIOUS DISEASES
- Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
- (2019) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection
- (2019) Ohad Etzion et al. JOURNAL OF HEPATOLOGY
- GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
- (2019) Heiner Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Identification of a Novel Deltavirus in Boa Constrictors
- (2019) Udo Hetzel et al. mBio
- Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
- (2019) Jimena Perez-Vargas et al. Nature Communications
- Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system
- (2019) Benjamin Y. Winer et al. HEPATOLOGY
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
- (2019) Markus Cornberg et al. JOURNAL OF HEPATOLOGY
- Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
- (2019) Tarik Asselah et al. Lancet Gastroenterology & Hepatology
- Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
- (2018) Cihan Yurdaydin et al. HEPATOLOGY
- Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks
- (2018) Jonathan Quinet et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a
- (2018) A. Vaillant et al. JOURNAL OF HEPATOLOGY
- Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
- (2018) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combinationwith Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial
- (2018) L. Allweiss et al. JOURNAL OF HEPATOLOGY
- Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes
- (2018) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Towards HBV curative therapies
- (2018) Raymond F. Schinazi et al. LIVER INTERNATIONAL
- Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?
- (2018) Tarik Asselah et al. LIVER INTERNATIONAL
- REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection
- (2018) Andrew Vaillant ACS Infectious Diseases
- Treating Chronic Hepatitis Delta: The Need for Surrogate Markers of Treatment Efficacy
- (2018) Cihan Yurdaydin et al. JOURNAL OF HEPATOLOGY
- A Divergent Hepatitis D-Like Agent in Birds
- (2018) Michelle Wille et al. Viruses-Basel
- Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
- (2017) Katja Giersch et al. GUT
- A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
- (2017) C. Koh et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
- (2017) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study
- (2017) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application
- (2017) Jianming Hu et al. Viruses-Basel
- Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
- (2017) Katja Giersch et al. Scientific Reports
- HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response
- (2016) G. A. Niro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes
- (2016) Dulce Alfaiate et al. ANTIVIRAL RESEARCH
- IFN-lambda therapy: current status and future perspectives
- (2016) Ahmed Lasfar et al. DRUG DISCOVERY TODAY
- Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
- (2016) Henry L.Y. Chan et al. JOURNAL OF HEPATOLOGY
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- The hepatitis delta virus: Replication and pathogenesis
- (2016) Camille Sureau et al. JOURNAL OF HEPATOLOGY
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3
- (2016) Graham R. Foster et al. SpringerPlus
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- (2016) Mamun Al-Mahtab et al. PLoS One
- Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
- (2015) Onur Keskin et al. Clinical Gastroenterology and Hepatology
- Pegylated interferon therapy of chronic hepatitis D: In need of revision
- (2015) Mario Rizzetto et al. HEPATOLOGY
- Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice
- (2015) Davor Slijepcevic et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- Hepatitis D Virus Replication
- (2015) John M. Taylor Cold Spring Harbor Perspectives in Medicine
- Long-term therapy of chronic delta hepatitis with peginterferon alfa
- (2014) T. Heller et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
- (2014) Stephan Urban et al. GASTROENTEROLOGY
- Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
- (2014) Benjamin Heidrich et al. HEPATOLOGY
- Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling
- (2014) Jeremie Guedj et al. HEPATOLOGY
- Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles
- (2014) N. Freitas et al. JOURNAL OF VIROLOGY
- Hepatitis Delta Antigen Requires a Flexible Quasi-Double-Stranded RNA Structure To Bind and Condense Hepatitis Delta Virus RNA in a Ribonucleoprotein Complex
- (2014) B. L. Griffin et al. JOURNAL OF VIROLOGY
- Hepatitis D Virus Coinfection and Superinfection
- (2014) F. Negro Cold Spring Harbor Perspectives in Medicine
- Nucleic Acid Polymers Prevent the Establishment of Duck Hepatitis B Virus InfectionIn Vivo
- (2013) Faseeha Noordeen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nucleic Acid Polymers Inhibit Duck Hepatitis B Virus InfectionIn Vitro
- (2013) Faseeha Noordeen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts
- (2013) Alexa Schieck et al. HEPATOLOGY
- Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection
- (2013) Shin-ichiro Nakagawa et al. PLoS One
- The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
- (2012) Tassilo Volz et al. JOURNAL OF HEPATOLOGY
- Large hepatitis delta antigen activates STAT-3 and NF-κB via oxidative stress
- (2012) V. Williams et al. JOURNAL OF VIRAL HEPATITIS
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Treatment Options for Hepatitis Delta Virus Infection
- (2012) Benjamin Heidrich et al. Current Infectious Disease Reports
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon Impedes an Early Step of Hepatitis Delta Virus Infection
- (2011) Ziying Han et al. PLoS One
- Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
- (2010) Carlos Castaneda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Natural history and treatment of chronic delta hepatitis
- (2010) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
- Solid-Phase Synthesis of the Lipopeptide Myr-HBVpreS/2-78, a Hepatitis B Virus Entry Inhibitor
- (2010) Alexa Schieck et al. MOLECULES
- Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead
- (2010) Heiner Wedemeyer et al. Nature Reviews Gastroenterology & Hepatology
- Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
- (2010) Jean-Pierre Vartanian et al. PLoS Pathogens
- A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
- (2009) Raffaella Romeo et al. GASTROENTEROLOGY
- Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene
- (2009) V. Williams et al. JOURNAL OF GENERAL VIROLOGY
- Modification of Small Hepatitis Delta Virus Antigen by SUMO Protein
- (2009) C.-H. Tseng et al. JOURNAL OF VIROLOGY
- Hepatitis Delta Antigen Requires a Minimum Length of the Hepatitis Delta Virus Unbranched Rod RNA Structure for Binding
- (2009) D. A. Defenbaugh et al. JOURNAL OF VIROLOGY
- The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III
- (2009) Valerie S. Greco-Stewart et al. VIROLOGY
- Hepatitis delta virus inhibits alpha interferon signaling
- (2008) Paolo Pugnale et al. HEPATOLOGY
- Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
- (2008) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
- Transcription of Subgenomic mRNA of Hepatitis Delta Virus Requires a Modified Hepatitis Delta Antigen That Is Distinct from Antigenomic RNA Synthesis
- (2008) C.-H. Tseng et al. JOURNAL OF VIROLOGY
- Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
- (2008) Joerg Petersen et al. NATURE BIOTECHNOLOGY
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
- (2008) Caroline Sommereyns et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now